EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC0

Gut mycobiome alterations and implications for liver diseases

Suling Zeng, Bernd Schnabl

PLOS Pathogens · 2024

DOI: 10.1371/journal.ppat.1012377 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift PLOS Pathogens, 2024. Verfasst von Suling Zeng und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Health and Medicine, Hefei Comprehensive National Science Center, Hefei, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Liver Diseases, Mycobiome, Dysbiosis. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: NIAAA NIH HHS, BLRD VA, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic liver disease and its complications are a significant global health burden. Changes in fungal communities (mycobiome), an integral component of the gut microbiome, are associated with and contribute to the development of liver disease. Fungal dysbiosis can induce intestinal barrier dysfunction and allow fungal products to translocate to the liver causing progression of disease. This review explores recent progress in understanding the compositional and functional diversity of gut mycobiome signatures across different liver diseases. It delves into causative connections between gut fungi and liver diseases. We emphasize the significance of fungal translocation, with a particular focus on fungal-derived metabolites and immune cells induced by fungi, as key contributors to liver disease. Furthermore, we review the potential impact of the intrahepatic mycobiome on the progression of liver diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeLiver DiseasesMycobiomeDysbiosisHumansAnimalsFungi

Autor:innen und Institutionen

  • Institute of Health and Medicine, Hefei Comprehensive National Science Center, Hefei, China.
  • Department of Medicine, University of California San Diego, La Jolla, California, United States of America.
  • Department of Medicine, VA San Diego Healthcare System, San Diego, California, United States of America.

Förderung

  • NIAAA NIH HHS
  • BLRD VA
  • NIDDK NIH HHS
  • Foundation for the National Institutes of Health
  • Biomedical Laboratory Research and Development, VA Office of Research and Development
  • Hefei Comprehensive National Science Center

Zitieren

APA

Zeng, S., & Schnabl, B. (2024). Gut mycobiome alterations and implications for liver diseases. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1012377

Vancouver

Zeng S, Schnabl B. Gut mycobiome alterations and implications for liver diseases. PLOS Pathogens. 2024. doi:10.1371/journal.ppat.1012377

BibTeX
@article{Zeng2024,
  author = {Zeng, Suling and Schnabl, Bernd},
  title = {Gut mycobiome alterations and implications for liver diseases},
  journal = {PLOS Pathogens},
  year = {2024},
  doi = {10.1371/journal.ppat.1012377}
}
Kostenlos starten →